Why the study?
Does telmisartan effectively reduce blood pressure in patients with mild-moderate hypertension?
Population
Preclinical models and patients with mild-moderate hypertension
Design
Review
Authors
Loading...
Supports sustained BP control with telmisartan in Japanese patients; leaves open confirmation in broader randomized trials.
Does telmisartan effectively reduce blood pressure in patients with mild-moderate hypertension?
Telmisartan is a potent, long-acting angiotensin II type-1 receptor blocker that provides sustained 24-hour blood pressure control in patients with mild-moderate hypertension.
Chachin et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: